DRY SHIPS, INC & NUPATHE, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed three positions; two for gains and one for a loss.

INNODATA ISOGEN (5/5/11). Closed position 12/5/11 at $4.30 for a 65% GAIN.

MGIC INVESTMENT (10/20/11). Closed position 12/5/11 at $3.55 for a 51% GAIN.

MOVE, INC. (1/5/08). Closed position 12/5/11 at $6.50 for a 32% LOSS.

(more…)

VERMILLION, INC & NEXXUS LIGHTING, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Just when it appeared that our Current Portfolio was digging out of the hole caused by the late summer massacre, POW! Europe raised its ugly head, again, and during the latter half of November the markets saw their worst action since the 1930s for that time period. When the financial media begins to use the 1930s as a comparison to present day ills, it’s not good. You have all heard and read about the reasons as to why the markets are caving, but the unspoken underlying reason is the simple fact that world leadership stinks, starting with our own.

(more…)

FSI INTERNATIONAL, INC. & ANADIGICS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed two positions; one for a very nice gain and one for a loss.

Net List (9/5/11). Closed position 11/15/11 at $3.15 for a 75% GAIN.

Bridgeline Digital (6/5/08). Closed position 11/15/11 at 70 cents for a 77% LOSS.

(more…)

ECOTALITY, INC. & BIODELIVERY SERVICES INT’L, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed three positions; two for some nice gains and one for a loss.

ADOLOR CORP (5/5/10). Closed position 10/24/11 at $4.42 for a 130% GAIN.

ANADYS PHARMACEUTICALS (8/20/09). Closed position 10/17/11 at $3.66 for a 60% GAIN.

NANOPHASE TECH (1/20/08). Closed position 10/21/11 at 59 cents for a 83% LOSS.

(more…)

BIOCRYST PHARMACEUTICALS, INC. & MGIC INVESTMENT CORPORATION

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

The first half of October felt as if the market had made a long-overdue prison break. The question is if this is the start of a new bull market or a rally in a bear market. The consensus, for now, rests with the latter opinion. We, of course, haven’t a clue, sorry to say. Our gut tells us that much of the near to mid-term market action depends upon what happens in Europe. Are France and Germany really prepared to bail out their troubled neighbors, as they boast, and are the European bankers ready to back them up? We hear what they have been saying, but actions are always another matter. Yes, this is just more ‘kicking the can down the road’, but it has let us sleep a little better, lately.

And, with the risk of sounding like a broken record, we did not close any positions in the Current Portfolio, which, though it looks a tad better, is still beaten to a pulp, despite positive news from many of the companies. As we said in the last Newsletter, and will keep saying it for a while, it will take smaller stocks much longer than the others to recover from the market mayhem of the last several months.

(more…)

CORCEPT THERAPEUTICS, INC. & KERYX BIOPHARMACEUTICALS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Not only did the markets throw out the baby with the bath water during most of September, they also threw out brothers, sisters, Mom, Dad, and the grandparents, along with gold and silver. However, toward the end of the month, the hint that the Fed, along with European banks, may launch some sort of QE3 gave the markets new hope. It is still our belief that this will come to pass. No, we are not proponents of more Fed intervention, but the central bankers have, in their minds, crossed the Rubicon.

(more…)

BIOMIMETIC THERAPEUTICS, INC. & CELLDEX THERAPEUTICS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Just when we thought it couldn’t get any worse, it did. And, yes, it has been a few years since our Current Portfolio has looked this badly; can you say 2008 during the heart of the financial crisis? Despite the fact that Doomsday is appearing just around the corner, we go back to our thoughts during May and June. Then, you may remember, we said that the Fed will not let the markets go completely in the tank for the simple reason that Chairman Ben has too much on the line. He is beyond the point of no-return. We are still expecting him to throw a few trillion more into the financial system, and that could come sooner than many anticipate. So, just hold tight a while longer.

(more…)

GLU MOBILE, INC. & NET LIST, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

And, once again, we must relay to you that the markets are still dicey and that our Current Portfolio remains in some sort of purgatory. In sum, except for the last eight trading days, August was a terrible month for the markets. Of course droughts in the West along with earthquakes and hurricanes in the East put some damper on investor enthusiasm. If there was a bright spot, it was the outcome of the Fed’s Jackson Hole conference when, after it was over, Chairman Ben said nothing about a possible QE3. Many market watchers are taking his silence as a good thing. They feel that at the Fed’s meeting later this month it will announce some sort of liquidity boost, and that thinking is what juiced the markets at the end of August. Time will tell. Remember, there are many mine fields out there, right now; let’s not forget about Europe!

(more…)

SYNTHESIS ENERGY SYSTEMS, INC. & NAUTILUS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

There is no way we can spin this. Our Current Portfolio has taken its worst drubbing since the end of 2008, when we had the last market crash. Yes, this has been a crash, albeit a mini-crash, but still a crash. The markets are adjusting to what they perceive to be the new reality of the future, whatever that may be. The question we need to ask is when do our portfolio picks become screaming buys? The answer is we don’t know but we suspect that day is coming soon, real soon.

(more…)

SATCON TECHNOLOGY CORPORATION & ANTARES PHARMA, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed one position for a minor loss.

ALLOS THERAPEUTICS (7/20/11). Closed position 7/21/11 at $1.84 for an 8% LOSS.

(more…)